The synthesis and the study of antimicrobial properties of 5-r,r’-aminometylene derivatives of thiazolidine-2,4-dione and 4-thioxothiazolidine-2-one
DOI:
https://doi.org/10.24959/ophcj.16.898Keywords:
4-thiazolidin(thi)one, 5-aminomethylene derivatives, multiresistance, antimicrobial activityAbstract
The study is devoted to the rational search of modern potential antimicrobial agents among of 4-thiazolidine(thi)ones. 5-R,R’-Enamin(thi)ones of thiazolidinone series have been tested for design and the initial screening of the antibacterial properties. The use of 5-ethoxymetylene derivatives of thiazolidine-2,4-dione and 4-thioxothiazolidin-2-one as effective “building blocks” for the synthesis of small libraries of bioactive compounds has been proposed. Nucleophilic substitution reactions between 5-ethoxymetylene derivatives and amino alcohols, the primary and secondary functionalized aromatic and heteroaromatic amines, heterocyclic amines (piperidine and substituted pyrazolines) have been studied. The pharmacological screening of the antimicrobial activity for the enamin(thi)ones synthesized on clinical isolates of staphylococci with different resistance mechanisms to protected β-lactams and multiresistance strains of E. coli and Ps. Aeruginosa has been performed. Compounds with a distinct antimicrobial effect have been identified. They can also increase the sensitivity of S. aureus and S. haemolyticus clinical strains to oxacillin, and can be used to create new combined antimicrobial chemotherapeutic agents. The “structure – antimicrobial activity” relationships for design and search for new antimicrobial agents have been analysed.Downloads
References
- http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/default.htm
- Chen L. F., Chopra T., Kaye K. S. Med. Clin. N. Am., 2011, Vol. 95, pp.647-676.
- Payne D. J. Nature Reviews. Drug Discovery, 2006, pp.29-40.
- Zervosen A. Antimicrob. Agents Chemother, 2004, Vol. 48, pp.961-969.
- Sim M. M. Bioorg. Med. Chem. Lett., 2002, Vol. 12, pp.697-699.
- Orchard M. D. Bioorg. Med. Chem. Lett., 2004, Vol. 14, pp.3975-3978.
- Grant B. E. Bioorg. Med. Chem. Lett., 2000, Vol. 10, pp.2179-2182.
- Gualtieri M. J. Antimicrob. Chemother., 2006, Vol. 58, pp.778-783.
- Golota S. Modern Directons in Chemistry, Biology, Pharmacy and Biotechnology, Lviv, 2015, pp.71-75.
- Ead H. A. Arch. Pharm. (Weinheim), 1987, Vol. 320, pp.1227-1231.
- Chopra I. Expert Opin. Investig. Drugs, 1997, Vol. 6, pp.1019-1024.
- Momose Y. Chem Pharm Bull., 1991, Vol. 39(6), pp.1440-1445.
- Mounyr B., Sadiki M., Ibnsouda S.-K. J. Pharm. Analysis, 2016, Vol. 6, No.2, pp.71-79.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).